Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

A weight-loss trial of the two drugs found one clear winner. In case you’re not totally clued up, Wegovy is just a different ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...

Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.

Often used as a weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the extra ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Mounjaro has been found to be more effective than Wegovy in the first direct comparison trial of two major weight-loss drugs.